Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease

被引:76
作者
Alcolea, Daniel [1 ,2 ]
Vilaplana, Eduard [1 ,2 ]
Pegueroles, Jordi [1 ,2 ]
Montal, Victor [1 ,2 ]
Sanchez-Juan, Pascual [2 ,3 ]
Gonzalez-Suarez, Andrea [1 ,2 ,3 ]
Pozueta, Ana [2 ,3 ]
Rodriguez-Rodriguez, Eloy [2 ,3 ]
Bartres-Faz, David [4 ,5 ]
Vidal-Pineiro, Didac [4 ,5 ]
Gonzalez-Ortiz, Sofa [6 ]
Medrano, Santiago [6 ]
Carmona-Iragui, Maria [1 ,2 ]
Sanchez-Saudinos, MaBelen [1 ,2 ]
Sala, Isabel [1 ,2 ]
Anton-Aguirre, Sofia [1 ,2 ]
Sampedro, Frederic [7 ]
Morenas-Rodriguez, Estrella [1 ,2 ]
Clarimon, Jordi [1 ,2 ]
Blesa, Rafael [1 ,2 ]
Lleo, Alberto [1 ,2 ]
Fortea, Juan [1 ,2 ]
机构
[1] Univ Autonoma Barcelona, St Pau Hosp St Pau, Inst Invest Biomed, Dept Neurol, E-08193 Barcelona, Spain
[2] Ctr Invest Biomed Red Enfermedades Neurodegenrat, Madrid, Spain
[3] Hosp Univ Marques de Valdecilla IDIVAL, Dept Neurol, Santander, Spain
[4] Univ Barcelona, Fac Med, Dept Psychiat & Clin Psychobiol, Barcelona 7, Spain
[5] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain
[6] Hosp Mar, Dept Radiol, Barcelona, Spain
[7] Univ Autonoma Barcelona, Fac Med, Barcelona, Spain
关键词
Cortical thickness; YKL-40; Neuroinflammation; Preclinical Alzheimer's disease; CSF biomarkers; Structural MRI; MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; BRAIN ATROPHY; BIOMARKERS; TAU; RECOMMENDATIONS; INFLAMMATION; A-BETA(42);
D O I
10.1016/j.neurobiolaging.2015.03.001
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Cerebrospinal fluid YKL-40 has been described as a marker of glial inflammation. We aimed to study the relationship between YKL-40 and brain structure and its interactions with core Alzheimer's disease (AD) biomarkers. We measured cortical thickness (CTh) and cerebrospinal fluid biomarkers (amyloid-beta 1-42 [A beta 42], total tau, p-tau, and YKL-40) of 80 cognitively normal controls and 27 patients with amnestic mild cognitive impairment. Subjects were classified as A beta 42+ (<550 pg/mL) or A beta 42- (>550 pg/mL). CTh difference maps were derived from the interaction and correlation analyses in the whole sample and within clinical groups. There was a strong correlation between YKL-40 and markers of neurodegeneration (total tau and p-tau). In the whole sample, we found a negative correlation between YKL-40 and CTh in AD vulnerable areas in A beta 42+ subjects but not in A beta 42 participants. Our results suggest that YKL-40 could track the inflammatory processes associated to tau-related neurodegeneration in the presence of the AD pathophysiological process. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:2018 / 2023
页数:6
相关论文
共 31 条
  • [1] Inflammation and Alzheimer's disease
    Akiyama, H
    Barger, S
    Barnum, S
    Bradt, B
    Bauer, J
    Cole, GM
    Cooper, NR
    Eikelenboom, P
    Emmerling, M
    Fiebich, BL
    Finch, CE
    Frautschy, S
    Griffin, WST
    Hampel, H
    Hull, M
    Landreth, G
    Lue, LF
    Mrak, R
    Mackenzie, IR
    McGeer, PL
    O'Banion, MK
    Pachter, J
    Pasinetti, G
    Plata-Salaman, C
    Rogers, J
    Rydel, R
    Shen, Y
    Streit, W
    Strohmeyer, R
    Tooyoma, I
    Van Muiswinkel, FL
    Veerhuis, R
    Walker, D
    Webster, S
    Wegrzyniak, B
    Wenk, G
    Wyss-Coray, T
    [J]. NEUROBIOLOGY OF AGING, 2000, 21 (03) : 383 - 421
  • [2] The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
    Albert, Marilyn S.
    DeKosky, Steven T.
    Dickson, Dennis
    Dubois, Bruno
    Feldman, Howard H.
    Fox, Nick C.
    Gamst, Anthony
    Holtzman, David M.
    Jagust, William J.
    Petersen, Ronald C.
    Snyder, Peter J.
    Carrillo, Maria C.
    Thies, Bill
    Phelps, Creighton H.
    [J]. ALZHEIMERS & DEMENTIA, 2011, 7 (03) : 270 - 279
  • [3] Relationship Between β-Secretase, Inflammation and Core Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
    Alcolea, Daniel
    Carmona-Iragui, Maria
    Suarez-Calvet, Marc
    Belen Sanchez-Saudinos, M.
    Sala, Isabel
    Anton-Aguirre, Sofia
    Blesa, Rafael
    Clarimon, Jordi
    Fortea, Juan
    Lleo, Alberto
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (01) : 157 - 167
  • [4] Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A Multicenter Study in Spain
    Alcolea, Daniel
    Martinez-Lage, Pablo
    Izagirre, Andrea
    Clerigue, Montserrat
    Carmona-Iragui, Maria
    Alvarez, Rosa Maria
    Fortea, Juan
    Balasa, Mircea
    Morenas-Rodriguez, Estrella
    Llado, Albert
    Grau, Oriol
    Blennow, Kaj
    Lleo, Alberto
    Molinuevo, Jose L.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2014, 39 (04) : 719 - 726
  • [5] Cerebrospinal Fluid Level of YKL-40 Protein in Preclinical and Prodromal Alzheimer's Disease
    Antonell, Anna
    Mansilla, Alicia
    Rami, Lorena
    Llado, Albert
    Iranzo, Alex
    Olives, Jaume
    Balasa, Mircea
    Sanchez-Valle, Raquel
    Luis Molinuevo, Jose
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (03) : 901 - 908
  • [6] Alzheimer's disease
    Scheltens, Philip
    De Strooper, Bart
    Kivipelto, Miia
    Holstege, Henne
    Chetelat, Gael
    Teunissen, Charlotte E.
    Cummings, Jeffrey
    van der Flier, Wiesje M.
    [J]. LANCET, 2021, 397 (10284) : 1577 - 1590
  • [7] CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
    Buerger, Katharina
    Ewers, Michael
    Pirttila, Tuula
    Zinkowski, Raymond
    Alafuzoff, Irina
    Teipel, Stefan J.
    DeBernardis, John
    Kerkman, Daniel
    McCulloch, Cheryl
    Soininen, Hilkka
    Hampel, Harald
    [J]. BRAIN, 2006, 129 : 3035 - 3041
  • [8] YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
    Craig-Schapiro, Rebecca
    Perrin, Richard J.
    Roe, Catherine M.
    Xiong, Chengjie
    Carter, Deborah
    Cairns, Nigel J.
    Mintun, Mark A.
    Peskind, Elaine R.
    Li, Ge
    Galasko, Douglas R.
    Clark, Christopher M.
    Quinn, Joseph F.
    D'Angelo, Gina
    Malone, James P.
    Townsend, R. Reid
    Morris, John C.
    Fagan, Anne M.
    Holtzman, David M.
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 68 (10) : 903 - 912
  • [9] del Campo M, 2012, BIOMARK MED, V6, P419, DOI [10.2217/BMM.12.46, 10.2217/bmm.12.46]
  • [10] Amyloid-β Associated Volume Loss Occurs Only in the Presence of Phospho-Tau
    Desikan, Rahul S.
    McEvoy, Linda K.
    Thompson, Wesley K.
    Holland, Dominic
    Roddey, J. Cooper
    Blennow, Kaj
    Aisen, Paul S.
    Brewer, James B.
    Hyman, Bradley T.
    Dale, Anders M.
    [J]. ANNALS OF NEUROLOGY, 2011, 70 (04) : 657 - 661